The MAP2K2 gene as Potential Diagnostic Marker in Monitoring Adalimumab Therapy of Psoriatic Arthritis.
Sign Up to like & getrecommendations! Published in 2022 at "Current pharmaceutical biotechnology"
DOI: 10.2174/1389201023666220628111644
Abstract: BACKGROUND MAP kinases are some of the cascades that are specialized in the cell's response to external stimuli. Their impaired functioning can be observed during the course of psoriatic arthritis. Currently, the best-known class of… read more here.
Keywords: map2k2 gene; group; adalimumab therapy; psoriatic arthritis ... See more keywords